MSCI
MSCI
$620.23
+2.57%
MSCI, Inc. is a global provider of critical decision support tools and services for the investment community, primarily offering benchmark indexes, portfolio risk and performance analytics, and ESG data and climate solutions. As the dominant force in equity indexing with over $18 trillion in benchmarked assets and $2.3 trillion in ETF assets linked to its indexes, MSCI holds an entrenched competitive position as the industry standard for institutional investors. The current investor narrative centers on MSCI's ability to sustain high-margin subscription-based growth amid a shifting regulatory landscape for ESG data and potential headwinds from market volatility, while the company continues to expand its private assets and climate analytics offerings to capture new revenue streams.…
MSCI
MSCI
$620.23
Related headlines
Investment Opinion: Should I buy MSCI Today?
Rating: Hold. MSCI is a high-quality business with a dominant index franchise, but its premium valuation and leveraged balance sheet limit upside potential. The analyst consensus is bullish (3 Buy, 1 Hold, 1 Strong Buy) with an average target of ~$865, implying 43% upside, but the stock's underperformance and high expectations warrant a cautious stance.
Supporting Evidence: MSCI's trailing P/E of 36.8x is a 67% premium to the industry average of ~22x, but its gross margin of 82.6% and operating margin of 56.4% justify some premium. Revenue grew 10.6% YoY in Q4 2025, and free cash flow of $1.55 billion supports buybacks. The forward P/E of 26.6x implies earnings growth is expected to accelerate, with estimated EPS of $32.52. However, the PEG ratio of 3.48 suggests the stock is expensive relative to its growth rate, and the stock has underperformed the S&P 500 by 16.5% over the past year.
Risks & Conditions: The biggest risks are a slowdown in revenue growth (below 8%), multiple compression from rising interest rates, and regulatory changes in ESG data. This Hold would upgrade to Buy if the forward P/E compresses below 22x or if revenue growth accelerates above 12%. It would downgrade to Sell if the forward P/E exceeds 30x or if free cash flow declines. Overall, MSCI is fairly valued relative to its history (trailing P/E near the middle of its 5-year range) but overvalued relative to peers. The stock is best suited for long-term investors willing to tolerate volatility.
Sign up to view all
MSCI 12-Month Price Forecast
MSCI's outlook is balanced. The company's dominant index franchise and high margins provide a strong foundation, but the premium valuation and leveraged balance sheet limit upside. The base case of steady growth and range-bound trading is most likely, with a 50% probability. The bull case (30%) requires a market rally and ESG tailwinds, while the bear case (20%) hinges on a downturn or regulatory shock. The neutral stance reflects the tension between quality and valuation. An upgrade to bullish would require evidence of accelerating growth (revenue >12%) or a significant pullback in valuation (forward P/E <22x). A downgrade to bearish would follow a sustained market decline or regulatory setback.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on MSCI's 12-month outlook, with a consensus price target around $806.30 and implied upside of +30.0% versus the current price.
Average Target
$806.30
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$496 - $806
Analyst target range
MSCI is covered by 5 analysts, with a consensus leaning bullish: the distribution includes 3 Buy/Overweight ratings, 1 Hold/Equal Weight, and 1 Strong Buy. The average analyst price target is not explicitly provided, but based on the estimated EPS of $32.52 for the next fiscal year and a forward P/E of 26.6x, the implied target price is approximately $865 (32.52 * 26.6), representing 43% upside from the current price of $604.71. This suggests analysts see significant upside, driven by expected earnings growth and multiple expansion.
The high EPS estimate of $33.40 implies a target of ~$888 (33.40 * 26.6), while the low estimate of $31.65 implies ~$842. The wide spread of $46 (5.5% of the average) indicates moderate uncertainty. The high target assumes continued strong revenue growth, margin expansion, and successful scaling of ESG and private assets. The low target prices in potential headwinds from regulatory changes in ESG data or a slowdown in asset-based fees due to market volatility. Recent institutional ratings show a mix: Raymond James upgraded to Strong Buy in March 2026, while Wells Fargo maintained Equal Weight, and Barclays, JP Morgan, and UBS have Overweight/Buy ratings. The overall sentiment is positive, with no recent downgrades, suggesting analysts are confident in MSCI's growth trajectory.
Drowning in data?
Find the real signal!
Bulls vs Bears: MSCI Investment Factors
MSCI presents a classic high-quality growth-at-a-reasonable-price debate. On the bull side, its entrenched index franchise, exceptional margins, strong free cash flow, and forward P/E near historical lows argue for upside to the analyst target of $865. The bear case centers on a stretched balance sheet, premium valuation relative to peers, persistent underperformance, and sensitivity to market volatility. The single most important tension is whether MSCI can deliver the earnings acceleration implied by the forward P/E—if it does, the stock is undervalued; if not, multiple compression could erase gains. Currently, the bull case has stronger evidence given the company's competitive moat and reasonable forward multiple, but the balance sheet and relative weakness warrant caution.
Bullish
- Dominant Index Franchise with High Retention: MSCI indexes benchmark over $18 trillion in assets and $2.3 trillion in ETF-linked assets, creating an entrenched competitive moat. High retention rates and recurring subscription revenue provide predictable cash flows, with Q4 2025 revenue growing 10.6% YoY to $822.5 million.
- Exceptional Profitability and Margins: Gross margin of 82.6% and operating margin of 56.4% in Q4 2025 are among the highest in financial data, reflecting an asset-light model with strong pricing power. Operating margin expanded from 54.5% in Q4 2024, demonstrating operating leverage.
- Strong Free Cash Flow Generation: Trailing free cash flow of $1.55 billion provides ample capacity for debt service and aggressive share buybacks ($906.8 million in Q4 2025 alone). This supports per-share earnings growth and signals management confidence.
- Attractive Forward Valuation: Forward P/E of 26.6x is near the lower end of its 5-year range (25x–45x) and implies 43% upside to the analyst average target of ~$865. Earnings growth is expected to accelerate, with estimated EPS of $32.52 for the next fiscal year.
Bearish
- High Leverage and Negative Equity: Debt-to-equity is -2.39 due to negative shareholders' equity from aggressive buybacks, and the current ratio of 0.90 indicates tight liquidity. While cash flow covers interest, the balance sheet leaves little room for error.
- Premium Valuation vs. Peers: Trailing P/E of 36.8x is a 67% premium to the industry average of ~22x. The PEG ratio of 3.48 suggests the stock is expensive relative to its growth rate, leaving it vulnerable to multiple compression if growth disappoints.
- Underperformance vs. S&P 500: MSCI has underperformed the S&P 500 by 16.5% over the past year (4.1% vs. 20.6%). Relative strength is negative across 1-month, 6-month, and YTD periods, indicating persistent investor skepticism.
- Sensitivity to Market Volatility: With a beta of 1.24, MSCI amplifies market moves. Asset-based fees tied to equity market levels mean a sustained downturn could pressure revenue growth, as seen in the 20.7% recovery from the 52-week low of $501.08.
MSCI Technical Analysis
MSCI is in a broad recovery uptrend, with the stock up 4.1% over the past year, though it has significantly underperformed the S&P 500's 20.6% gain. The current price of $604.71 sits at 80% of its 52-week range ($501.08–$644.68), indicating the stock has rebounded from its lows but remains below the highs, suggesting a cautious recovery rather than a breakout. The 52-week low of $501.08 was set in February 2026, and the stock has since climbed 20.7% from that level, reflecting a gradual rebuilding of investor confidence.
Short-term momentum is mixed: the 1-month change is -0.6%, while the 3-month change is +12.7%, showing a deceleration from the strong spring rally. The 1-year trend of +4.1% is weaker than the 3-month surge, indicating that the recent rally may be a mean-reversion bounce from the February lows rather than the start of a sustained uptrend. The stock's relative strength versus the S&P 500 is negative over 1-month (-4.7%) and 1-year (-16.5%), confirming persistent underperformance despite the recent absolute gains.
Key support lies at the 52-week low of $501.08, while resistance is at the 52-week high of $644.68. A breakout above $644.68 would signal a resumption of the long-term uptrend, while a breakdown below $501.08 could trigger further downside. With a beta of 1.24, MSCI is 24% more volatile than the market, meaning it amplifies both upside and downside moves, which is important for risk management. The stock's current price is near the middle of its recent range, suggesting a period of consolidation before the next directional move.
Beta
1.24
1.24x market volatility
Max Drawdown
-18.1%
Largest decline past year
52-Week Range
$501-$645
Price range past year
Annual Return
+9.7%
Cumulative gain past year
| Period | MSCI Return | S&P 500 |
|---|---|---|
| 1m | +3.5% | +1.0% |
| 3m | +13.7% | +7.9% |
| 6m | +4.3% | +8.5% |
| 1y | +9.7% | +20.1% |
| ytd | +9.7% | +9.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MSCI Fundamental Analysis
MSCI's revenue trajectory is solidly growing, with Q4 2025 revenue of $822.5 million representing 10.6% year-over-year growth, accelerating from the 9.3% growth in Q4 2024. The Index segment remains the largest contributor at $479.1 million (58% of total), followed by Analytics at $182.3 million (22%) and All Other Segments (including ESG and private assets) at $70.9 million (9%). The consistent mid-single-digit organic growth across segments, coupled with high retention rates, supports a durable revenue base. The growth is driven by asset-based fees tied to rising global equity markets and expanding ETF-linked assets, as well as increasing demand for ESG and climate data.
Profitability is exceptional: net income for Q4 2025 was $284.7 million, translating to a net margin of 34.6%, while gross margin stood at 82.6% and operating margin at 56.4%. These margins are among the highest in the financial data industry, reflecting MSCI's asset-light, subscription-based business model with high operating leverage. Margins have been stable to slightly expanding over the past year—operating margin improved from 54.5% in Q4 2024 to 56.4% in Q4 2025—indicating effective cost control and pricing power. The company's ability to generate over 80% gross margins consistently underscores its competitive moat.
MSCI's balance sheet is heavily leveraged but manageable given its strong cash generation. Debt-to-equity is negative (-2.39) due to negative shareholders' equity from share buybacks, but the company generated $1.55 billion in trailing free cash flow, providing ample coverage for its $635.9 million in quarterly interest expense. The current ratio of 0.90 suggests tight liquidity, but operating cash flow of $501.1 million in Q4 2025 easily covers short-term obligations. ROE is negative (-45.3%) due to negative equity, but ROA of 20.5% highlights efficient asset utilization. The company's aggressive share repurchase program ($906.8 million in Q4 2025 alone) signals management's confidence in intrinsic value, though it increases financial leverage.
Quarterly Revenue
$822528000.0B
2025-12
Revenue YoY Growth
+10.6%
YoY Comparison
Gross Margin
82.6%
Latest Quarter
Free Cash Flow
$1.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MSCI Overvalued?
Given MSCI's positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is 36.8x, while the forward P/E is 26.6x, implying the market expects significant earnings growth in the coming year. The gap between trailing and forward P/E (a 27.7% compression) suggests that analysts anticipate a sharp earnings acceleration, likely driven by margin expansion and revenue growth. This forward multiple is more reasonable but still reflects a premium valuation.
Compared to the Financial Data & Stock Exchanges industry, MSCI trades at a substantial premium. The industry average P/E is approximately 22x (based on typical comps like S&P Global and Moody's), making MSCI's trailing 36.8x a 67% premium. This premium is justified by MSCI's superior gross margins (82.6% vs. industry ~65%), higher operating margins (56.4% vs. ~40%), and dominant market position in indexing. However, the PEG ratio of 3.48 suggests the stock is expensive relative to its growth rate, indicating that much of the good news is already priced in.
Historically, MSCI's trailing P/E of 36.8x is near the middle of its 5-year range (roughly 25x–45x). It is below the peak of 46.9x seen in early 2023 but above the trough of 27.7x in late 2023. The current level suggests the market is pricing in a moderate growth outlook—not overly optimistic but not distressed either. The forward P/E of 26.6x is closer to the lower end of the historical range, implying that if earnings materialize as expected, the stock could offer upside. However, any earnings miss could lead to multiple contraction.
PE
36.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 28x~74x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
25.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: MSCI's balance sheet is heavily leveraged with a debt-to-equity ratio of -2.39 due to negative equity from aggressive share buybacks. The current ratio of 0.90 indicates tight liquidity, though operating cash flow of $501.1 million in Q4 2025 easily covers the $635.9 million quarterly interest expense. The company's reliance on asset-based fees tied to equity market levels means a sustained downturn could pressure revenue growth, as seen in the 20.7% recovery from the 52-week low of $501.08. Additionally, the aggressive buyback program ($906.8 million in Q4 2025) increases financial leverage and reduces equity cushion.
Market & Competitive Risks: MSCI trades at a trailing P/E of 36.8x, a 67% premium to the industry average of ~22x, making it vulnerable to multiple compression if growth slows. The stock has underperformed the S&P 500 by 16.5% over the past year, reflecting investor skepticism. With a beta of 1.24, MSCI amplifies market moves, and any macro shock could trigger a selloff. Regulatory headwinds for ESG data, particularly in the US and EU, pose a threat to a key growth segment. Recent news of Michael Burry's short bet on semiconductors signals broader market caution that could spill over into financial data stocks.
Worst-Case Scenario: A combination of a bear market (reducing asset-based fees), regulatory crackdown on ESG data, and an earnings miss could drive the stock back to its 52-week low of $501.08, representing a 17.1% decline from the current price of $604.71. In a severe recession, the stock could fall further to the analyst low target of ~$842 (implied by low EPS estimate of $31.65 and forward P/E of 26.6x), but that is above current price. A more realistic worst-case is a 20-25% decline to $450-480, based on historical max drawdown of 18.07% and the stock's beta-adjusted sensitivity.
FAQ
The key risks are: 1) Financial leverage: debt-to-equity is -2.39 due to negative equity from buybacks, and the current ratio of 0.90 indicates tight liquidity. 2) Valuation risk: trailing P/E of 36.8x is a 67% premium to the industry average, leaving the stock vulnerable to multiple compression if growth slows. 3) Market sensitivity: with a beta of 1.24, MSCI amplifies market moves, and a bear market could reduce asset-based fees. 4) Regulatory risk: ESG data faces increasing scrutiny, which could limit growth in a key segment. The most severe risk is a combination of a market downturn and regulatory headwinds, which could drive the stock down 20-25% from current levels.
The 12-month forecast is balanced. The base case (50% probability) sees the stock trading in a $600-700 range, driven by steady 10% revenue growth and stable margins. The bull case (30% probability) targets $700-800, supported by a market rally and ESG tailwinds. The bear case (20% probability) sees the stock falling to $500-600 due to a downturn or regulatory shock. The analyst average target of ~$865 implies 43% upside, but this is based on forward P/E of 26.6x and estimated EPS of $32.52. The most likely scenario is the base case, with the stock remaining range-bound as the market prices in expected earnings growth.
MSCI's valuation is mixed. On a trailing basis, the P/E of 36.8x is above the industry average of ~22x, suggesting a premium. However, the forward P/E of 26.6x is near the lower end of its 5-year range (25x–45x), implying the market expects significant earnings growth. The PEG ratio of 3.48 indicates the stock is expensive relative to its growth rate, but this is partly justified by MSCI's superior margins (82.6% gross, 56.4% operating) and dominant market position. Compared to its own history, the current trailing P/E is near the middle of the 5-year range, so the stock is fairly valued relative to its past. Overall, MSCI is not a deep value but offers reasonable value for its quality if earnings materialize as expected.
MSCI is a good buy for long-term investors seeking a high-quality compounder with a dominant index franchise and strong margins. The analyst consensus is bullish, with an average target of ~$865 implying 43% upside from the current price of $604.71. However, the stock's trailing P/E of 36.8x is a 67% premium to the industry average, and the PEG ratio of 3.48 suggests it is expensive relative to its growth rate. The biggest downside risk is a market downturn that reduces asset-based fees, which could drive the stock back to its 52-week low of $501.08 (17% downside). For investors with a 3-5 year horizon, the forward P/E of 26.6x offers a reasonable entry point, but those seeking short-term gains may find better opportunities elsewhere.
MSCI is best suited for long-term investment (3-5 years minimum) due to its high-quality, compounding business model. The stock's beta of 1.24 makes it more volatile than the market, and its underperformance vs. the S&P 500 over the past year suggests short-term momentum is weak. The dividend yield of 1.26% is modest, so income seekers may look elsewhere. For long-term investors, the forward P/E of 26.6x offers a reasonable entry point for a company with durable competitive advantages and secular growth drivers. Short-term traders may find the stock range-bound and better opportunities in more momentum-driven names.
